Home002294 • SHE
add
Shenzhen Salubris Pharmaceuticals Co Ltd
Previous close
¥29.86
Day range
¥29.56 - ¥30.08
Year range
¥23.50 - ¥38.10
Market cap
33.27B CNY
Avg Volume
4.60M
P/E ratio
54.22
Dividend yield
1.68%
Primary exchange
SHE
Market news
Investor's Business Daily
51 minutes ago
How DeepSeek AI Sparks Nearly $1 Trillion U.S. Tech Implosion
0.13%
0.00%
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 958.43M | 24.15% |
Operating expense | 512.65M | 45.09% |
Net income | 165.62M | 17.01% |
Net profit margin | 17.28 | -5.78% |
Earnings per share | — | — |
EBITDA | 279.38M | 19.13% |
Effective tax rate | 5.44% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.91B | -4.84% |
Total assets | 10.23B | 8.51% |
Total liabilities | 1.59B | 6.97% |
Total equity | 8.64B | — |
Shares outstanding | 1.11B | — |
Price to book | 3.87 | — |
Return on assets | 4.96% | — |
Return on capital | 5.93% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 165.62M | 17.01% |
Cash from operations | 320.85M | 76.79% |
Cash from investing | -533.90M | -36.02% |
Cash from financing | 308.40M | 245.90% |
Net change in cash | 88.19M | 170.79% |
Free cash flow | -1.21B | -19.69% |
About
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company.
Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.
Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
Founded
Nov 3, 1998
Website
Employees
3,517
